Paragon Care Limited

Symbol: PGC.AX

ASX

0.31

AUD

Market price today

  • 28.5712

    P/E Ratio

  • 1.7515

    PEG Ratio

  • 207.04M

    MRK Cap

  • 0.02%

    DIV Yield

Paragon Care Limited (PGC-AX) Stock Price & Analysis

Shares Outstanding

0M

Gross Profit Margin

0.17%

Operating Profit Margin

0.08%

Net Profit Margin

0.03%

Return on Assets

0.02%

Return on Equity

0.03%

Return on Capital Employed

0.07%

Company general description and statistics

Sector: Healthcare
Industry: Medical - Distribution
CEO:Mr. John Andrew Walstab
Full-time employees:400
City:Scoresby
Address:Waterman Business Centres
IPO:1999-10-15
CIK:

Paragon Care Limited supplies durable medical equipment, medical devices, and consumable medical products to health and aged care markets in Australia, New Zealand, and internationally. The company offers clinical solutions for anaesthetists, intensivists, cardiac, vascular, and pain management; designs, manufactures, and distributes reagent red blood cells, monoclonal blood grouping reagents, and ancillary products for immunohaematology laboratories; and eye care products, such as ophthalmology and optometry, neonatal vision screening, and procedural kits. It also provides neonatal and paediatric assessment and treatment, including newborn hearing and vision screening, jaundice management, targeted temperature management, cerebral function monitoring, and seizure detection, as well as pain management and enteral feeding solutions; surgical products for hip and knee arthroplasty, infection prevention, pain management, biologics, and the operating room; and equipment repair and maintenance services. In addition, the company offers sterilisable transducers for surgical procedures such as neurology, hepatobiliary, renal, colorectal, vascular, laparoscopic, and robotic procedures; ultrasound systems, shockwave therapy, lasers, and accessories for infection control; and veterinary products, including point-of-care diagnostics, therapeutic lasers, oncology delivery products, centrifuges, autoclaves, IV lines and fluid therapy products, wearable CRI systems, and IT Solutions. Further, it provides telephony, nurse call, access control, CCTV, cordless, and Wi-Fi products. The company was formerly known as Citrofresh International Limited and changed its name to Paragon Care Limited in June 2008. Paragon Care Limited was incorporated in 1994 and is based in Melbourne, Australia.

General Outlook

When we look at how much money they make before expenses, they keep 0.169% as profit. This shows they're good at controlling costs and are financially stable. Their operating profit, which is money made from regular business activities, is 0.082%. This means they run their business efficiently. Lastly, after paying all their bills, they still have a profit of 0.027%. This tells us they're good at keeping money after all costs.

Return on Investments

The company's asset efficiency, represented by a robust 0.017% return, is a testament to Paragon Care Limited's adeptness in optimizing resource deployment. Paragon Care Limited's utilization of its assets to generate profits is strikingly evident through a noteworthy return on equity of 0.034%. Furthermore, the proficiency of Paragon Care Limited in capital utilization is underscored by a remarkable 0.069% return on capital employed.

Stock Prices

Paragon Care Limited's stock prices have been subject to undulating patterns. The peak stock value during this interval surged to $0.33, while its low point bottomed out at $0.315. This variance in figures offers investors a lucid insight into the roller-coaster ride that is Paragon Care Limited's stock market.

Liquidity Ratios

Analyzing PGC.AX liquidity ratios reveals its financial health of the firm. The current ratio of 130.37% gauges short-term asset coverage for liabilities. The quick ratio (63.64%) assesses immediate liquidity, while the cash ratio (26.56%) indicates cash reserves.

cards.indicatorcards.value
Current Ratio130.37%
Quick Ratio63.64%
Cash Ratio26.56%

Profitability Ratios

PGC.AX profitability indicators offer a lens into its earnings landscape. A pretax profit margin of 4.90% underscores its earnings before tax deductions. The effective tax rate stands at 22.22%, revealing its tax efficiency. The net income per EBT, 54.47%, and the EBT per EBIT, 59.64%, provide insights into its earnings hierarchy. Lastly, with an EBIT per revenue ratio of 8.21%, we grasp its operational profitability.

cards.indicatorcards.value
Pretax Profit Margin4.90%
Effective Tax Rate22.22%
Net Income per EBT54.47%
EBT per EBIT59.64%
EBIT per Revenue8.21%

Operational Efficiency

Operational metrics shed light on its business agility. With an operating cycle of 1.30, it details the span from stock purchase to revenue. The 1 days it takes to settle debts showcases its creditor relations.

cards.indicatorcards.value
Days of Sales Outstanding64
Days of Inventory Outstanding89
Operating Cycle134.67
Days of Payables Outstanding55
Cash Conversion Cycle80
Receivables Turnover7.91
Payables Turnover6.62
Inventory Turnover4.12
Fixed Asset Turnover4.82
Asset Turnover0.65

Cash Flow Ratios

Peering into the cash flow metrics reveals liquidity and operational efficiency. The operating cash flow per share, 0.04, and free cash flow per share, -0.01, depict cash generation on a per-share basis. The cash per share value, 0.04, showcases liquidity position. A payout ratio of 0.32 highlights the portion of earnings distributed as dividends. Lastly, the operating cash flow sales ratio, 0.09, offers insight into cash flow relative to sales.

cards.indicatorcards.value
Operating Cash Flow per Share0.04
Free Cash Flow per Share-0.01
Cash per Share0.04
Payout Ratio0.32
Operating Cash Flow Sales Ratio0.09
Free Cash Flow to Operating Cash Flow Ratio-0.34
Cash Flow Coverage Ratio0.23
Short Term Coverage Ratio0.86
Capital Expenditure Coverage Ratio0.75
Dividend Paid and Capex Coverage Ratio0.70
Dividend Payout Ratio0.05

Debt and Leverage Ratios

Diving into debt and leverage metrics unveils the company's financial structure. The debt ratio, at 24.45%, highlights its total liabilities relative to assets. With a debt-equity ratio of 0.47, we discern the balance between debt and equity financing. The long-term debt to capitalization, 25.36%, and total debt to capitalization, 31.78%, ratios shed light on its capital structure. An interest coverage of 3.22 indicates its ability to manage interest expenses.

cards.indicatorcards.value
Debt Ratio24.45%
Debt Equity Ratio0.47
Long Term Debt to Capitalization25.36%
Total Debt to Capitalization31.78%
Interest Coverage3.22
Cash Flow to Debt Ratio0.23
Company Equity Multiplier1.91

Per Share Data

Speaking about the per share data offers a perceptive view of financial distribution. The revenue per share, 0.47, provides a glimpse into top-line earnings distributed across each share. Net income per share, 0.02, reflects the portion of profit attributed to each share. The book value per share, 0.37, represents the net asset value distributed per share, while the tangible book value per share, -0.40, excludes intangible assets.

cards.indicatorcards.value
Revenue Per Share0.47
Net Income Per Share0.02
Book Value Per Share0.37
Tangible Book Value Per Share-0.40
Shareholders Equity Per Share0.37
Interest Debt Per Share0.15
Capex Per Share-0.03

Growth Ratios

Delving into growth metrics provides a snapshot of financial expansion. The revenue growth rate, 5.12%, indicates top-line expansion, while the gross profit growth, 13.86%, reveals profitability trends. EBIT growth, 7.62%, and operating income growth, 7.62%, offer insights into operational profitability progression.

cards.indicatorcards.value
Revenue Growth5.12%
Gross Profit Growth13.86%
EBIT Growth7.62%
Operating Income Growth7.62%
EPS Growth-40.41%
EPS Diluted Growth-40.42%
Weighted Average Shares Growth34.41%
Weighted Average Shares Diluted Growth34.48%
Operating Cash Flow Growth-48.95%
Free Cash Flow Growth-57.15%
10-Year Revenue Growth per Share46.29%
5-Year Revenue Growth per Share-18.77%
3-Year Revenue Growth per Share-26.00%
10-Year Operating CF Growth per Share102.83%
10-Year Net Income Growth per Share-9.68%
5-Year Net Income Growth per Share-72.91%
3-Year Net Income Growth per Share-46.71%
10-Year Shareholders Equity Growth per Share129.21%
5-Year Shareholders Equity Growth per Share-37.96%
3-Year Shareholders Equity Growth per Share-13.50%
10-Year Dividend per Share Growth per Share258.79%
5-Year Dividend per Share Growth per Share-24.89%
3-Year Dividend per Share Growth per Share-36.14%
Receivables Growth63.81%
Inventory Growth-0.24%
Asset Growth49.71%
Book Value per Share Growth44.51%
Debt Growth16.15%

Other Metrics

Venturing into other key metrics unveils diverse facets of financial performance. The enterprise value, 253,541,736.665, captures the company's total value, considering both debt and equity. Income quality, 1.38, assesses the reliability of reported earnings. The sales, general, and administrative to revenue ratio, 0.23, gauges operational efficiency, while the research and development to revenue, 0.56%, highlights investment in innovation. The ratio of intangibles to total assets, 114.02%, indicates the value of non-physical assets, and capex to operating cash flow, -118.58%, measures reinvestment capability.

cards.indicatorcards.value
Enterprise Value253,541,736.665
Income Quality1.38
Sales General and Administrative to Revenue0.23
Research and Development to Revenue0.56%
Intangibles to Total Assets114.02%
Capex to Operating Cash Flow-118.58%
Capex to Revenue-6.84%
Capex to Depreciation-204.43%
Stock-Based Compensation to Revenue0.11%
Graham Number0.37
Return on Tangible Assets-17.11%
Graham Net Net-0.17
Working Capital39,098,000
Tangible Asset Value-259,439,000
Net Current Asset Value-63,913,000
Average Receivables41,173,500
Average Payables30,101,000
Average Inventory57,572,500
Days Sales Outstanding47
Days Payables Outstanding52
Days of Inventory On Hand91
ROIC5.97%
ROE0.04%

Valuation Ratios

Exploring the valuation ratios offers insights into perceived market value. The price to book value ratio, 0.95, and the price to book ratio, 0.95, reflect the market's valuation relative to the company's book value. The price to sales ratio, 0.77, provides a perspective on valuation in relation to sales. Ratios like price to free cash flows, -26.11, and price to operating cash flows, 8.72, gauge market valuation against cash flow metrics.

cards.indicatorcards.value
Price Book Value Ratio0.95
Price to Book Ratio0.95
Price to Sales Ratio0.77
Price Cash Flow Ratio8.72
Price Earnings to Growth Ratio1.75
Enterprise Value Multiple3.32
Price Fair Value0.95
Price to Operating Cash Flow Ratio8.72
Price to Free Cash Flows Ratio-26.11
Price to Tangible Book Ratio0.63
Enterprise Value to Sales0.82
Enterprise Value Over EBITDA6.91
EV to Operating Cash Flow14.28
Earnings Yield6.99%
Free Cash Flow Yield-2.14%
security
Trusted project
“All information displayed on the site is verified. High quality project and financial performance”
Eugene Alexeev
NumFin Founder and investing enthusiast

Frequently Asked Question

How many company shares are outstanding in 2024?

There are stock number shares outstanding of Paragon Care Limited (PGC.AX) on the ASX in 2024.

What is P/E ratio of enterprise in 2024?

The current P/E ratio of enterprise is 28.571 in 2024.

What is the ticker symbol of Paragon Care Limited stock?

The ticker symbol of Paragon Care Limited stock is PGC.AX.

What is company IPO date?

IPO date of Paragon Care Limited is 1999-10-15.

What is company current share price?

Current share price is 0.310 AUD.

What is stock market cap today?

The market cap of stock today is 207039080.000.

What is PEG ratio in 2024?

The current 1.752 is 1.752 in 2024.

What is the number of employees in 2024?

In 2024 the company has 400.